Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 68 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →
Share price
₹1,159.50
Market cap
₹1,16,673 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
25.9×Sector 47.4×
Promoter holding
75.01%+0.01% QoQ
FII holding
6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:21 IST BSE
Results Update

Zydus Lifesciences Results Update

Zydus Lifesciences reported FY26 revenues of ₹27,148 Crore and approved a ₹1,100 Crore share buyback. Strong performance across segments supports the multi-year growth outlook.

Value
₹1,100 Cr